4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-027292
EVP, CHIEF FINANCIAL OFFICER sold 10,259 shares at $16.81 ($172,454)
- EVP, CHIEF FINANCIAL OFFICER acquired 19,826 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-11-17 | Option exercise | +9,913 | 53,648 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-11-17 | Option exercise | +9,913 | 63,561 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-11-19 | Sale | −10,259 | $16.81 | $172,454 | 53,302 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-11-17 | Option exercise · Restricted Stock Units | −9,913 | 9,913 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-11-17 | Option exercise · Restricted Stock Units | −9,913 | 9,913 | D | ||
| Open-market sales · 10,259 sh · avg $16.81 · $172,454 | |||||||
Loading xslF345X05/form4-11202024_011103.xml…